SWOF researchers to present 10 abstracts at 2022 San Antonio Breast Cancer Symposium
• Adding a year of everolimus to adjuvant endocrine therapy did not improve IDFS or OS in HR+, HER2- breast ...
• Adding a year of everolimus to adjuvant endocrine therapy did not improve IDFS or OS in HR+, HER2- breast ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2023 Scienmag- Science Magazine: Latest Science News.
© 2023 Scienmag- Science Magazine: Latest Science News.